Soho Flordis International (SFI) has the ambition to be a global leader in premium natural healthcare solutions, and is leveraging extensive M&A activities to reach this goal. Group head of business development Michele Genovesi discusses the group’s aims and strategy, and explains how Ticino based Ginsana SA – now SFI Switzerland – came to be a regional headquarters and center of excellence for the group.
Michele, as this is the first time Pharmaboardroom has met with Soho Flordis International, to begin could you please introduce the group to our readers?
"From source to patient, SFI aims to develop natural healthcare products proven to be effective with dedicated clinical trials, and is committed to sourcing quality ingredients through rigorous processes"
